⌘K

Home/Filings/4/0001104659-21-045963

4//SEC Filing

Jafri Hasan 4

Accession 0001104659-21-045963

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 12:43 PM ET

Size

5.1 KB

Accession

0001104659-21-045963

Insider Transaction Report

Form 4

Period: 2021-04-01

Aridis Pharmaceuticals, Inc.ARDS

Chief Medical Officer

Transactions

Award
Stock Options
2021-04-01+10,000→ 90,000 total
Exercise: $5.90Exp: 2031-04-01→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The stock options vest in equal installments over 48 months, beginning on April 1, 2021.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1

filerCIK 0001815352

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 12:43 PM ET
Size: 5.1 KB

View on SEC.gov